Título : CLL crosstalk with naïve T cells enhances the differentiation of IL-22-producing T cells and CLL -cell survival
Autor(es) : Ferrer, Gerardo
Palacios, Florencia
Chiu, Pui Yan
Wong, Kelly
Bueno-Costa, Alberto
Barrientos, Jacqueline C.
Kolitz, Jonathan E.
Allen, Steven L.
Rai, Kanti R.
Chen, Shih-Shih
Barbara, Sherry
Chiorazzi, Nicholas
Fecha de publicación : 22-nov-2024
Tipo de publicación: Artículo
Versión: Aceptado
Publicado por: Nature
Publicado en: Leukemia
Areas del conocimiento : Ciencias Naturales y Exactas
Ciencias Biológicas
Bioquímica y Biología Molecular
Otros descriptores : Cancer
immunology
leukemia
Resumen : Patients with chronic lymphocytic leukemia (CLL) exhibit clinical findings suggesting an altered immune system, with an increased risk of infection and the development of other cancers and various autoimmune phenomena. These associations are thought to be orchestrated in part by the interactions of leukemic cells with normal cells and elements in tissues, the latter referred to as the tumor microenvironment (TME). Notably, these interactions support the survival and expansion of CLL cells. Most well studied is the impact of the leukemic cells on T cells, leading to alterations in T-cell subset composition, surface membrane molecule expression, immune-synapse formation, and migration, along with functional changes such as exhaustion. Nevertheless, the molecular mechanisms by which differentiation of naive T (Tn) cells to various memory T-cell subsets occurs in CLL and the effects of imbalances of the process on leukemic B-cell survival and disease progression are not fully understood. Our results suggest a previously unrecognized positive loop involving IL-22-producing T cells, CLL B cells, and T cells in the TME that contributes to the maintenance of the leukemic clone and inuences patient outcomes. Deciphering this complex interplay within the CLL TME might provide insights that could inform future therapeutic strategies.
URI / Handle: https://hdl.handle.net/20.500.12381/3867
DOI: https://doi.org/10.1038/s41375-024-02463-9
Institución responsable del proyecto: Instituto de investigación en Cáncer, Josep Carreras, España
Institut Pasteur de Montevideo
The Feinstein Institutes For Medical Research, Estados Unidos
Centro de Investigación Biomédica en Red Cáncer (CIBERONC), España
Department of Medicine, Northwell Health, Estados Unidos
Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Estados Unidos
Department of Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/ Northwell, Estados Unidos
Financiadores: Fundación Científica AECC
NIH National Cancer Institute
CLL Global Research Foundation
The Nash Family Foundation
The Muriel Fusfeld Foundation
Jean Walton Fund for Leukemia, Lymphoma, and Myeloma Research.
Nivel de Acceso: Acceso abierto
Licencia CC: Reconocimiento-NoComercial 4.0 Internacional. (CC BY-NC)
Aparece en las colecciones: Institut Pasteur de Montevideo

Archivos en este ítem:
archivo  Descripción Tamaño Formato
41375_2024_Article_2463.pdfDescargar 830.67 kBAdobe PDF

Las obras en REDI están protegidas por licencias Creative Commons.
Por más información sobre los términos de esta publicación, visita: Reconocimiento-NoComercial 4.0 Internacional. (CC BY-NC)